As of Jul 31, 2026, Pharma-Bio Serv, Inc. had total assets of $11.4 million and total liabilities of $994,740. Total assets were down 15.8% from a year earlier. Stockholders' equity was $10.4 million. It held $8.6 million in cash and investments against $0 of total debt, net cash of $8.6 million. The current ratio, current assets divided by current liabilities, was 11.30.
USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jul 31, 2026
|
FY 2025
Oct 31, 2025
|
FY 2024
Oct 31, 2024
|
FY 2023
Oct 31, 2023
|
FY 2022
Oct 31, 2022
|
FY 2021
Oct 31, 2021
|
FY 2020
Oct 31, 2020
|
FY 2019
Oct 31, 2019
|
FY 2018
Oct 31, 2018
|
FY 2017
Oct 31, 2017
|
FY 2016
Oct 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash |
2
-61.6%
|
3
-50.1%
|
7
-35.2%
|
10
-27.8%
|
14
-17.2%
|
17
+1.9%
|
17
+10.6%
|
15
-3.4%
|
16
+38.3%
|
12
-15.8%
|
14
-7.5%
|
| Short-term investments |
7
+4.3%
|
7
+25.0%
|
6
+31.9%
|
5
|
—
|
—
|
—
|
0
-100.0%
|
0
+67.2%
|
0
+31.1%
|
0
-39.3%
|
| Cash and investments |
9
-20.0%
|
11
-14.8%
|
13
-14.9%
|
15
+3.6%
|
14
-17.2%
|
17
+1.9%
|
17
+10.6%
|
15
-3.6%
|
16
+38.4%
|
12
-15.8%
|
14
-7.6%
|
| Receivables |
2
+20.1%
|
2
-6.0%
|
3
-36.3%
|
4
-20.9%
|
5
+8.0%
|
5
-52.6%
|
10
+10.8%
|
9
+69.1%
|
5
-17.8%
|
6
-7.8%
|
7
-8.0%
|
| Total current assets |
11
-14.6%
|
13
-14.7%
|
16
-19.1%
|
19
-2.7%
|
20
-12.6%
|
23
-20.2%
|
29
+10.0%
|
26
+10.9%
|
23
+8.0%
|
22
+0.2%
|
22
-7.0%
|
| Property and equipment, net |
0
-39.1%
|
0
-31.4%
|
0
+415.3%
|
0
-55.4%
|
0
-30.2%
|
0
-51.5%
|
0
-25.1%
|
0
-2.5%
|
0
+18.9%
|
0
-89.3%
|
2
+173.3%
|
| Total assets |
11
-15.8%
|
14
-16.2%
|
16
-18.1%
|
20
-3.6%
|
21
-13.7%
|
24
-20.0%
|
30
+12.3%
|
27
+4.9%
|
25
+13.5%
|
22
-6.9%
|
24
-0.6%
|
| Liabilities and equity | |||||||||||
| Total current liabilities |
1
-40.0%
|
2
-7.9%
|
2
-12.4%
|
2
+2.2%
|
2
-21.0%
|
3
-29.6%
|
4
+3.3%
|
4
+43.1%
|
3
+66.3%
|
2
-28.5%
|
2
+1.6%
|
| Total liabilities |
1
-40.0%
|
2
-32.5%
|
3
-31.7%
|
4
-7.8%
|
4
-18.3%
|
5
-30.5%
|
7
+19.5%
|
6
+17.8%
|
5
+219.1%
|
2
-26.7%
|
2
+0.5%
|
| Stockholders' equity |
10
-12.4%
|
12
-13.1%
|
14
-15.0%
|
16
-2.6%
|
17
-12.5%
|
19
-16.7%
|
23
+10.2%
|
21
+1.7%
|
20
-2.3%
|
21
-4.9%
|
22
-0.7%
|
| Debt | |||||||||||
| Lease liabilities |
0
-100.0%
|
0
-85.1%
|
0
-44.0%
|
0
-28.9%
|
0
-21.1%
|
1
-28.2%
|
1
|
—
|
—
|
—
|
—
|
| Total debt |
0
-100.0%
|
0
-85.1%
|
0
-44.0%
|
0
-28.9%
|
0
-21.1%
|
1
-28.2%
|
1
|
—
|
—
|
—
|
—
|
| Net cash |
9
-19.5%
|
11
-13.7%
|
13
-14.2%
|
15
+4.7%
|
14
-17.1%
|
17
+3.5%
|
16
|
—
|
—
|
—
|
—
|
| Ratios | |||||||||||
| Current ratio |
11.30x
|
7.70x
|
8.32x
|
9.01x
|
9.46x
|
8.55x
|
7.54x
|
7.08x
|
9.13x
|
14.05x
|
10.02x
|
| Debt to equity |
0.00x
|
0.00x
|
0.01x
|
0.02x
|
0.03x
|
0.03x
|
0.04x
|
—
|
—
|
—
|
—
|
| Debt to EBITDA |
—
|
—
|
—
|
0.30x
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Return on equity |
2.41%
|
-0.84%
|
-5.67%
|
8.12%
|
6.08%
|
-11.05%
|
9.03%
|
10.13%
|
6.32%
|
-6.82%
|
-1.18%
|
| Return on assets |
2.20%
|
-0.74%
|
-4.77%
|
6.58%
|
4.87%
|
-8.73%
|
6.85%
|
7.84%
|
5.04%
|
-6.33%
|
-1.07%
|
| Book value per share |
0.46
|
0.52
|
0.60
|
0.70
|
0.72
|
0.82
|
0.99
|
0.90
|
0.88
|
0.90
|
0.95
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.
Company profile
- Industry
- Services-Management Consulting Services (SIC 8742)
- Listed as
- PBSV (OTC)
- Fiscal year ends
- October 31
- Headquarters
- Dorado, PR
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1304161
- Former names
- LAWRENCE CONSULTING GROUP INC (until Feb 28, 2006)
Other Services-Management Consulting Services companies
- Cgi Inc GIB
- Booz Allen Hamilton Holding Corp BAH
- Genpact LTD G
- Fti Consulting, Inc FCN
- Exponent Inc EXPO
- Huron Consulting Group Inc. HURN
- Astrana Health, Inc. ASTH
- ICF International, Inc. ICFI
Source: SEC EDGAR filings. This is company-reported data, not investment advice.